SCHEMBL855052

SCHEMBL855052

CCN1CCC(C(=O)O)CC1

nearest known ligand 0.67

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.67
HSD11B1 P28845 2/20 0.48
LMNA P02545 2/20 0.44
S1PR5 Q9H228 2/20 0.43
L3MBTL1 Q9Y468 2/20 0.42
ALDH1A1 P00352 1/20 0.42
S1PR4 O95977 1/20 0.42
S1PR1 P21453 1/20 0.42
S1PR3 Q99500 1/20 0.42
KDM4E B2RXH2 1/20 0.41
USP2 O75604 1/20 0.41
HPGD P15428 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
HSD17B10 Q99714 1/20 0.41
PLG P00747 1/20 0.40
PLAT P00750 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL6997154 0.98 SMN1; SMN2 (0.64) SMN1; SMN2HSD11B1LMNAS1PR5L3MBTL1
Acetic Acid SCHEMBL7372307 0.96 SMN1; SMN2 (0.62) SMN1; SMN2HSD11B1LMNAS1PR5L3MBTL1
SCHEMBL9370255 0.92 SMN1; SMN2 (0.58) SMN1; SMN2HSD11B1LMNAS1PR5ALDH1A1
SCHEMBL2086743 0.89 SMN1; SMN2 (0.55) SMN1; SMN2HSD11B1LMNAS1PR5ALDH1A1
SCHEMBL1309271 0.88 SMN1; SMN2 (0.53) SMN1; SMN2HSD11B1LMNAS1PR5ALDH1A1
Hydrochloric Acid SCHEMBL23453806 0.87 SMN1; SMN2 (0.54) SMN1; SMN2HSD11B1S1PR5L3MBTL1ALDH1A1
SCHEMBL13739335 0.87 SMN1; SMN2 (0.57) SMN1; SMN2HSD11B1S1PR5ALDH1A1S1PR4
SCHEMBL934458 0.87 SMN1; SMN2 (0.57) SMN1; SMN2HSD11B1S1PR5ALDH1A1S1PR4
SCHEMBL13740434 0.87 SMN1; SMN2 (0.57) SMN1; SMN2HSD11B1S1PR5ALDH1A1S1PR4
Hydrochloric Acid SCHEMBL28596153 0.85 SMN1; SMN2 (0.55) SMN1; SMN2HSD11B1S1PR5L3MBTL1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 405 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3967714-B1 VINYL ALCOHOL-AMINO ACID ESTER COPOLYMER, THEIR PREPARATION AND USES SEKISUI CHEMICAL CO LTD (JP) 2026-01-07 EP claimed
EP-3215489-B1 METHOD FOR THE PREPARATION OF 1-(2-HALOGEN-ETHYL)-4 PIPERIDINE-CARBOXYLIC ACID ETHYL ESTERS OLON SPA (IT) 2019-07-24 EP claimed
US-10023535-B2 Method for the preparation of 1-(2-halogen-ethyl)-4 piperidine-carboxylic acid ethyl esters OLON S.P.A. (IT) 2018-07-17 US claimed
US-20170313657-A1 METHOD FOR THE PREPARATION OF 1-(2-HALOGEN-ETHYL)-4 PIPERIDINE-CARBOXYLIC ACID ETHYL ESTERS OLON S.P.A. (IT) 2017-11-02 US claimed
EP-3215489-A1 METHOD FOR THE PREPARATION OF 1-(2-HALOGEN-ETHYL)-4 PIPERIDINE-CARBOXYLIC ACID ETHYL ESTERS OLON S.p.A. (IT) 2017-09-13 EP claimed
WO-2016071792-A1 METHOD FOR THE PREPARATION OF 1-(2-HALOGEN-ETHYL)-4 PIPERIDINE-CARBOXYLIC ACID ETHYL ESTERS LABORATORIO CHIMICO INTERNAZIONALE S.P.A. (IT) 2016-05-12 WO claimed
US-8716296-B2 Inhibitors of protein kinases INGENIUM PHARMACEUTICALS GMBH (DE) 2014-05-06 US claimed
EP-2245011-A1 NOVEL PIPERIDINE-4-CARBOXYLIC ACID PHENYL-ALKYL-AMIDE DERIVATIVES AND THEIR USE AS MONOAMINE NEUROTRANSMITTER RE-UPTAKE INHIBITORS NeuroSearch A/S (DK) 2010-11-03 EP claimed
WO-2009090173-A1 NOVEL PIPERIDINE-4-CARBOXYLIC ACID PHENYL-ALKYL-AMIDE DERIVATIVES AND THEIR USE AS MONOAMINE NEUROTRANSMITTER RE-UPTAKE INHIBITORS NEUROSEARCH A/S (DK) 2009-07-23 WO claimed
EP-1761542-B1 OCTAHYDROPYRROLO[3,4-C]PYRROLE DERIVATIVES AN THEIR USE AS ANTIVIRAL AGENTS HOFFMANN LA ROCHE (CH) 2008-01-02 EP claimed
CN-101001860-A Heterocyclic antiviral compounds ROCHE PALO ALTO LLC (CH) 2007-07-18 CN claimed
EP-0387057-B1 Surface-treating agents for copper and copper alloy TOKAI ELECTRO CHEMICAL CO (JP) 1993-10-20 EP claimed
US-12636368-B2 Ionizable lipids for nucleic acid delivery GLOBAL LIFE SCIENCES SOLUTIONS CANADA ULC (CA) 2026-05-26 US disclosed
US-12600909-B2 Etching solution composition RASA INDUSTRIES, LTD. (JP) 2026-04-14 US disclosed
US-20260078085-A1 IONIZABLE LIPIDS FOR NUCLEIC ACID DELIVERY GLOBAL LIFE SCIENCES SOLUTIONS CANADA ULC (CA) 2026-03-19 US disclosed
US-12503432-B2 Ionizable lipids for nucleic acid delivery GLOBAL LIFE SCIENCES SOLUTIONS CANADA ULC (CA) 2025-12-23 US disclosed
US-4950674-A Arylalkylheterocyclic amines,N-substituted by aryloxyalkyl group in a method for allergy treatment A. H. ROBINS COMPANY, INCORPORATED (US) 1990-08-21 US disclosed
EP-0300462-A2 Heterocyclic peroxycarboxylic acids AUSIMONT S.p.A. (IT) 1989-01-25 EP disclosed
EP-0068669-A1 Secondary phenylethanol amines, processes for their preparation and their pharmaceutical application BEECHAM GROUP PLC (GB) 1983-01-05 EP disclosed
US-3983173-A ANTIBIOTIC HOECHST AKTIENGESELLSCHAFT (DT) 1976-09-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10023535-B2 Method for the preparation of 1-(2-halogen-ethyl)-4 piperidine-carboxylic acid ethyl esters UMPS, UCK2, EFTUD2 SMN1; SMN2 3940/4885HSD11B1 3002/4885LMNA 2211/4885
US-12636368-B2 Ionizable lipids for nucleic acid delivery NSUN2, NSUN3, RNMT SMN1; SMN2 546/4885HSD11B1 2811/4885LMNA 120/4885
US-20260078085-A1 IONIZABLE LIPIDS FOR NUCLEIC ACID DELIVERY NSUN2, NSUN3, H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16 SMN1; SMN2 425/4885HSD11B1 2725/4885LMNA 62/4885
US-12503432-B2 Ionizable lipids for nucleic acid delivery RNASEH1, NSUN3, SLC67A1 SMN1; SMN2 450/4885HSD11B1 4197/4885LMNA 336/4885
US-20170313657-A1 METHOD FOR THE PREPARATION OF 1-(2-HALOGEN-ETHYL)-4 PIPERIDINE-CARBOXYLIC ACID ETHYL ESTERS UMPS, UCK2, EFTUD2 SMN1; SMN2 3940/4885HSD11B1 3002/4885LMNA 2211/4885
US-12600909-B2 Etching solution composition ASIC3, GRIN2D, ASIC1 SMN1; SMN2 768/4885HSD11B1 617/4885LMNA 2491/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.